Phase II study of ICRF-159 in patients with metastatic colorectal carcinoma previously exposed to systemic chemotherapy

Cancer Treat Rep. 1976 Sep;60(9):1395-7.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aged
  • Colonic Neoplasms / drug therapy*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Metastasis
  • Piperazines / therapeutic use*
  • Razoxane / adverse effects
  • Razoxane / therapeutic use*
  • Rectal Neoplasms / drug therapy*

Substances

  • Piperazines
  • Razoxane